health 🔬 Fridge-free vaccines show promise for global health
Human trials for a new 'fridge-free' tetanus-diphtheria booster vaccine, SPVX02, have successfully concluded. This trial took place in the UK, involving healthy adults who received the vaccine. The formula remains viable for at least 24 months at temperatures up to 30°C as of the study. This could drastically cut down on vaccine waste and logistical issues in hot or remote areas. Larger Phase II and Phase III trials are planned to move this technology forward.